Updated results of Transpher A: multicenter, single-dose, phase 1/2 clinical trial of ABO-102 for Sanfilippo syndrome type A (mucopolysaccharidosis IIIA)

被引：0
|
作者：
Flanigan, Kevin [1 ]
Smith, Nicholas [2 ]
Couce, Maria [3 ]
Escolar, Maria [4 ]
Truxal, Kristen [1 ]
McBride, Kim [1 ]
de Castro, Maria [3 ]
Fuller, Maria [2 ]
Paneda, Astrid [5 ]
Ruiz, Juan [5 ]
机构：
[1] Nationwide Childrens Hosp, Columbus, OH USA
[2] Womens & Childrens Hosp, Adelaide, SA, Australia
[3] Hosp Clin Univ Santiago de Compostela, Santiago De Compostela, Spain
[4] Univ Pittsburgh, Med Ctr, Pittsburgh, PA 15260 USA
[5] Abeona Therapeut, Dallas, TX USA
来源：
MOLECULAR GENETICS AND METABOLISM | 2021年 / 132卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
eP203
引用
收藏
页码：S133 / S134
页数：3
相关论文
共 42 条
  • [31] Single-dose AAV9-CLN6 gene transfer slows the decline in motor and language function in variant late infantile neuronal ceroid lipofuscinosis 6: Interim results from phase 1/2 trial
    de los Reyes, Emily
    Aylward, Shawn
    Meyer, Kathrin
    Lehwald, Lenora
    Albright, Charles
    Rogers, David L.
    Castelli, Jeff
    Jiang, Hai
    Goldman, Mitchell
    Jain, Vipul
    di Ronza, Alberto
    Barth, Jay A.
    MOLECULAR GENETICS AND METABOLISM, 2021, 132 (02) : S32 - S33
  • [32] UPDATED RESULTS FROM A MULTICENTER, OPEN-LABEL, DOSE-ESCALATION PHASE 1B/2 STUDY OF SINGLE-AGENT OPROZOMIB (OPZ) IN PATIENTS (PTS) WITH HEMATOLOGIC MALIGNANCIES, INCLUDING MULTIPLE MYELOMA (MM)
    Vij, R.
    Savona, M.
    Siegel, D.
    Kaufman, J. L.
    Badros, A.
    Ghobrial, I.
    Paner, A.
    Jagannath, S.
    Jakubowiak, A.
    Mikhael, J.
    Kapoor, P.
    Neuman, L.
    Obreja, M.
    Berdeja, J.
    HAEMATOLOGICA, 2015, 100 : 251 - 251
  • [33] AAV8-Mediated Liver-Directed Gene Therapy as a Potential Therapeutic Option in Adults with Glycogen Storage Disease Type Ia (GSDIa): Updated Phase 1/2 Clinical Trial Results
    Rodriguez-Buritica, David F.
    Ahmad, Ayesha
    Pico, Mari Luz Couce
    Derks, Terry G.
    Mitchell, John
    Riba-Wolman, Rebecca
    Mou, Jiani
    Poma, Allen
    Valayannopoulos, Vassili
    Crombez, Eric
    MOLECULAR THERAPY, 2021, 29 (04) : 134 - 135
  • [34] Satisfy: A Eurobloodnet Multicenter, Single-Arm Phase 2 Trial of Mitapivat in Adult Patients with Erythrocyte Membranopathies and Congenital Dyserythropoietic Anemia Type II- Results from the 8-Week Dose-Escalation Period
    Doeven, Thomas
    Van Beers, Eduard J.
    van Wijk, Richard
    Groot, Evelyn
    Saes, Joline L.
    Bos, Jennifer
    De Wilde, Jonathan R. A.
    Rab, Minke A. E.
    Bendtsen, Selma K.
    Petersen, Jesper
    Vejlstrup, Niels G.
    Helby, Jens
    Gladieux, Adeline
    Chermat, Fatiha
    Fenaux, Pierre
    Kuo, Kevin H. M.
    Glenthrj, Andreas
    BLOOD, 2024, 144 : 3831 - 3832
  • [35] Updated results of anlotinib combined with TQB2450 (PD-L1 blockade) as first-line treatment for advanced esophageal squamous cell carcinoma (ESCC): A single-arm, multicenter, open-label phase. clinical trial
    Zhang, Zhiye
    Meng, Xiangrui
    Yang, Xiuli
    Hong, Yong-Gui
    Xia, Jin
    Chen, Yunfang
    Wu, Tao
    Shan, Zheng-Zheng
    Fan, Qingxia
    Wang, Feng
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [36] PD-1 inhibitor (sintilimab) and fruquintinib plus SOX as conversion therapy for initially unresectable gastric/gastroesophageal junction adenocarcinoma (GC/GEJC): Updated results from a single-arm, phase 2 clinical trial.
    Ma, Fei
    Luo, Suxia
    Zhang, Bin
    Ma, Qi
    Ji, Sheqing
    Zhang, Zhandong
    Zhang, Yonglei
    Yang, Wei
    Peng, Liangqun
    Guo, Dandan
    Ren, Jinjun
    Zhang, Yuan
    Su, Yueyue
    Li, Jing
    Liu, Wentao
    Huang, Jinxi
    Yuan, Weiwei
    JOURNAL OF CLINICAL ONCOLOGY, 2025, 43 (4_SUPPL) : 406 - 406
  • [37] A phase III clinical trial of GC1111 as an enzyme replacement therapy in previously untreated mucopolysaccharidosis type II (Hunter syndrome) patients: A double-blind, randomized, activecontrolled (part 1) and open-labeled, historical placebocontrolled (part 2) study
    Jin, Dongkyu
    Kim, Jinsup
    Yang, Aram
    Shin, SooKyung
    MOLECULAR GENETICS AND METABOLISM, 2024, 141 (02)
  • [38] Safety and efficacy of low-dose PI3K inhibitor taselisib in adult patients with CLOVES and Klippel-Trenaunay syndrome (KTS): the TOTEM trial, a phase 1/2 multicenter, open-label, single-arm study
    Luu, M.
    Vabres, P.
    Devilliers, H.
    Loffroy, R.
    Phan, A.
    Martin, L.
    Morice-Picard, F.
    Petit, F.
    Willems, M.
    Bessis, D.
    Jacquemont, M. L.
    Maruani, A.
    Chiaverini, C.
    Mirault, T.
    Clayton-Smith, J.
    Carpentier, M.
    Fleck, C.
    Maurer, A.
    Yousfi, M.
    Parker, V. E. R.
    Semple, R. K.
    Bardou, M.
    Faivre, L.
    GENETICS IN MEDICINE, 2021, 23 (12) : 2433 - 2442
  • [39] Updated interim safety, biomarker, and efficacy data from Imagine-1: A phase 1/2 open-label, multicenter study to assess the safety, tolerability, and efficacy of a single dose, intra-cisterna magna (ICM) administration of PBGM01 in subjects with type I (early onset) and type IIA (late onset) infantile GM1 gangliosidosis (GM1)
    Jarnes, Jeanine R.
    Hastings, Caroline A.
    Ficicioglu, Can H.
    Day-Salvatore, Debra-Lynn
    Giugliani, Roberto
    Baruteau, Julien
    Whitley, Chester B.
    Inbar-Feigenberg, Michal
    Bernard, Genevieve
    Ezgu, Fatih S.
    Ni, Yan G.
    Miller, Michelle
    Gelb, Michael H.
    Nagilla, Pruthvi
    Johnstone, Rose
    Elsasser, Patricia
    Cunningham, Elizabeth
    Ballard, Victoria
    Haws, Thomas F.
    Forman, Mark S.
    Weinstein, David A.
    MOLECULAR GENETICS AND METABOLISM, 2023, 138 (02) : 68 - 68
  • [40] Preliminary Results from a Phase 1b/2 Open-Label, Multicenter, Dose Optimization Clinical Study of the Safety, Tolerability, and Pharmacokinetic (PK) and Pharmacodynamic (PD) Profiles of Cfi-400945 As a Single Agent or in Combination with Azacitidine in Patients (Pts) with Acute Myeloid Leukemia, Myelodysplastic Syndrome or Chronic Myelomonocytic Leukemia ( TWT-202)
    Jonas, Brian A.
    Yee, Karen
    Mims, Alice
    Koller, Paul B.
    Brandwein, Joseph
    Roboz, Gail J.
    Michelson, Glenn
    Linh Nguyen
    Bray, Mark R.
    Roberts-Thomson, Emily
    Sidhu, Roger
    Borthakur, Gautam
    BLOOD, 2023, 142
12345